Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Algernon Pharmaceuticals Inc
AGNPF
Primary Symbol:
C.AGN
Consumer Cyclical
Healthcare
Advertising Agencies
Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N...
-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:AGN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Comment by
nodaytrader
on Jul 13, 2022 5:51pm
RE:Chattering Investment Groups Eh?
"Wall Street has rejected throwing money at Algernon's massive dilution " WHO? Name them! Just asking.
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Jul 13, 2022 2:37pm
Chattering Investment Groups Eh?
From stocktwits @boogawooga102 It's old news!!! They have been talking about a July dat dump for months now. PLEASE NAME THE CHATTERING investor groups. Otherwise, what's the point? Algernon
...more
Fintech Select LTD. Publishes Results for Fiscal Year 2023
posted May 01, 2024 9:00am by
Fintech Select Ltd.
-
|
Under the leadership of Fintech Select's management, the Company achieved a significant milestone in revenue generation, reaching $3,822,182 for fiscal year 2023, compared to $2,587,867 in 2022. Management is confident this 47% increase on a year-over-year basis ...read more
(7)
•••
SkynetMoney
X
View Profile
View Bullboard History
Post by
SkynetMoney
on Jul 13, 2022 12:47pm
Phase 2 Proof of Concept Study Topline Data Out This Month
Hearing some chatter in some private investor groups about their June 13th news release where they cleary announced topline data will be available in July. Could be a major catalyst for re-rating of
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Jul 12, 2022 2:39pm
Bellus Health or Belly Up
It looks like the Peacock of Pennyland is on the penny circuit trying to explain away the companies pivot to running all Phase 1 studies after 4 years of ranting about starting at Phase 2. It blows
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Jul 12, 2022 10:05am
Everyone know this is now a bogus statement.
Under Algernon's "Reorganization" (100 to 1 Reverse Split) they have taken the pipeline backwards to Phase 1 studies. They already spend a lot of time at Phase 2 because they are not
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Jul 11, 2022 8:04am
You're Screwed - Period
See stocktwits yahoo ihub ceo.ca... algernonpharma.com
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 11, 2022 7:00am
New Press Release - Algernon Pharmaceuticals Provides Update on its Planned Phase 1 Repirinast Chronic Kidney Disease Study
VANCOUVER, British Columbia, July 11, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage Canadian pharmaceutical development company, is pleased to provide an update on its chronic kidney disease (“CKD...
read article.
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Jul 09, 2022 2:48pm
RE:RE:RE:RE:RE:Trading below PP
June 2020 for your reference
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Jul 09, 2022 2:47pm
RE:RE:RE:RE:Trading below PP
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Jul 09, 2022 10:22am
Unlucky or just plain stupid?
The fire in Romania (COVID study) *The #1 successful containment in the entire world for COVID in South Korea (COVID study) *The lockdown of the entire country of Australia due to COVID-19 (IPF
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Comment by
C10H12N2
on Jul 09, 2022 10:20am
RE:RE:LOL... they're paying for a header on a website that...
The @ss clown who just makes sh!t up as she goes along on all the message boards stalking me. Always claiming to have told me something. Hasn't a clue about any of my holdings. Just a sick
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Jul 07, 2022 9:34pm
RE:LOL... they're paying for a header on a website that...
LOL... I told you that at .35 and you called me a basher, sad it took you a year and BAGHOLDER status to figure out penny land! Typical
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Jul 07, 2022 8:31pm
LOL... they're paying for a header on a website that...
steps all on top of their news releases with other news stories from whoever wherever. Just burning money. Crazy.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 07, 2022 7:00am
New Press Release - Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study
VANCOUVER, British Columbia, July 07, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage Canadian pharmaceutical development company, is pleased to provide an update on its planned Phase 1 clinical...
read article.
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Jul 05, 2022 9:30am
Algernon is 8 Million USD short of money they stated they...
needed to run their longshot Phase 1 studies while Chronic Cough sits indefinitely on the back burner getting cold. Weeeee DMT for brain surgery!
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results